Lucile Packard Children's Hospital Stanford
Palo Alto, California, 94304, United States
NCT Number: NCT06922032
This mixed-methods study seeks to evaluate the feasibility of Mystic Pets software and hardware within the pediatric population. This study will take place at Lucile Packard Children's Hospital (Stanford University, Palo Alto, CA).
Trial opening soon.
Get Notified4 year–17 year
All sexes
Interventional
Not applicable
Palo Alto, California, 94304, United States
Hospitalized children often experience emotional distress related to medical procedures, unfamiliar environments, and limited control over their situations. Existing distraction techniques, such as traditional videos and gaming, often rely heavily on visual interfaces, which can be limiting in clinical contexts. Current immersive technology software and hardware for procedural distraction rely on partial to complete immersion in a computer-generated environment to the real world. While immersive technology can reduce emotional distress with distraction, some patients experience increased distress due to loss of visual connection with their surroundings and/or caregivers. Using a head-mounted device and hand-gesture inputs, Mystic Pets maintains visual contact with a person's surroundings while gameplay is advanced through audio input and hand-gestures.
This research will significantly contribute to the growing field of digital therapeutics by providing early-stage data on a novel, immersive technology tailored to pediatric clinical care. If proven feasible, Mystic Pets could expand the toolkit available for procedural distraction, enhance patient comfort, and reduce the reliance on pharmacological interventions for emotion distress management.
The study also aims to establish preliminary engagement and usability benchmarks to guide future development and deployment of similar technologies in hospital environments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive the game intervention and be instructed to wear a Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in Mystic Pets software game (Stanford Chariot Program, Palo Alto, CA) that is specifically designed to promote overall distraction and emotional distress reduction.
Time frame: immediately after intervention
Participants will provide qualitative feedback on the acceptability and feasibility of the use of Mystics Pets. Example question will include: "Can you please tell me about your experience?"
Time frame: immediately after intervention
The scale has 6 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
Time frame: immediately after intervention
The scale has 10 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
Time frame: immediately after intervention
Game Engagement score measured by Game Engagement Questionnaire. The scale has 16 items. Scores ranges from 1-5 (1 = strongly disagree and 5 = strongly agree)
Time frame: immediately after intervention
The scale has 12 items. Scores ranges from 1-7 (1 = strongly disagree and 7 = strongly agree)
Contact information is provided by the study sponsor or research team.
Man Yee Suen, MMedSc
CONTACT
Thomas Caruso, MD, PhD
CONTACT
Stanford University
Other
A Novel Auditory Application for Distraction in Pediatric Patients: A Pilot Feasibility and Acceptability Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715916
Emotional Distress
View Trial DetailsNCT07667894
Deglutition Disorders, Digestive System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07662070
Emotional Distress, Gastric Adenocarcinoma
View Trial DetailsNCT07331324
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial Details